Spanish healthcare firm Grifols (GRLS.MC) has agreed to give U.S. regulators 30 days notice of when it hopes to close its $4 billion agreed deal to buy U.S. peer Talecris (TLCR.O). In a regulatory filing with the Securities and Exchange Commission, Grifols said closure of the deal would not be before March 21 but is waiting on the U.S. Federal Trade Commission (FTC) to make a ruling on whether the deal can go ahead. Last week Grifols said it expected a ruling from the FTC by March 6.
Source
